Entering text into the input field will update the search result below

Savara rises as Jefferies upgrades citing 100% upside

May 16, 2023 9:25 AM ETSavara Inc. (SVRA)By: Dulan Lokuwithana, SA News Editor
Wall Street New York City

aluxum

Savara (NASDAQ:SVRA), a biotech focused on respiratory disorders, added ~7% pre-market Tuesday after Jefferies upgraded its shares to Buy from Hold citing over 100% upside in the event of a positive Phase 3 readout from its lead program molgramostim.

The once-daily inhaled

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About SVRA

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SVRA--
Savara Inc.
CRBU--
Caribou Biosciences, Inc.
GRCL--
Gracell Biotechnologies Inc.
CDNA--
CareDx, Inc
AVXL--
Anavex Life Sciences Corp.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.